| http://www.w3.org/ns/prov#value | - by the Environmental Protection Agency prior to enforcement action, and if not, if review preclusion is a violation of the Due Process Clause.(01-09-2012)Caraco v. Novo NordiskAdministrative Law: Whether the provision in the Hatch-Waxman Act allowing generic drug manufacturers to ???counterclaim??? and seek an FDA order requiring changes by the patent holder applies to (1) approved methods of use
|
